{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T16:12:54Z","timestamp":1760890374914,"version":"3.44.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.cbi.2021.109604","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T10:44:50Z","timestamp":1627901090000},"page":"109604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Enhanced purification protocol for the angiotensin-converting enzyme from bovine systems and investigation of the in vitro effect of some active substances"],"prefix":"10.1016","volume":"347","author":[{"given":"Fatih","family":"Karahan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vedat","family":"Turkoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2021.109604_bib1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/375146a0","article-title":"Male-female differences in fertility and blood pressure in ACE-deficient mice","volume":"375","author":"Krege","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2021.109604_bib2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1172\/JCI66541","article-title":"Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's like cognitive decline","volume":"124","author":"Bernstein","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cbi.2021.109604_bib3","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s12010-012-0024-y","article-title":"Review on the angiotensin-converting-enzyme (ACE) inhibitor peptides from marine proteins","volume":"169","author":"He","year":"2013","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.cbi.2021.109604_bib4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/15216549800201942","article-title":"Purification of swine serum angiotensin converting enzyme with high recovery of activity using lisinopril coupled to epoxy-activated sepharose 6B","volume":"44","author":"Quassinti","year":"1998","journal-title":"IUBMB Life"},{"key":"10.1016\/j.cbi.2021.109604_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF03179884","article-title":"Purified angiotensin converting enzyme from Rana esculenta ovary influences ovarian steroidogenesis in vitro","volume":"59","author":"Miano","year":"2003","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.cbi.2021.109604_bib6","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.procbio.2013.05.005","article-title":"Purification and biochemical characterization of angiotensin I-converting enzyme (ACE) from ostrich lung: the effect of 2,2,2-trifluoroethanol on ACE conformation and activity","volume":"48","author":"Mojallal-Tabatabei","year":"2013","journal-title":"Process Biochem."},{"key":"10.1016\/j.cbi.2021.109604_bib7","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s11696-019-00806-w","article-title":"In vitro effect of ethyl acetate, butanol and water extracts of Juniperus excelsa Bieb. on Angiotensin Converting Enzyme purified from human plasma","volume":"73","author":"Basi","year":"2019","journal-title":"Chem. Pap."},{"key":"10.1016\/j.cbi.2021.109604_bib8","first-page":"71","article-title":"Hypertension: pathophysiology and treatment","volume":"4","author":"Foex","year":"2004","journal-title":"Cont. Educ. Anaesth. Crit. Care Pain"},{"key":"10.1016\/j.cbi.2021.109604_bib9","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2174\/1381612820666141024151119","article-title":"Antihypertensive drugs metabolism: an update to pharmacokinetic profiles and computational approaches","volume":"21","author":"Zisaki","year":"2015","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.cbi.2021.109604_bib10","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1161\/01.CIR.0000075957.16003.07","article-title":"What is an angiotensin converting enzyme inhibitor","volume":"108","author":"Sweitzer","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2021.109604_bib11","first-page":"37","article-title":"Beta-blockers in the treatment of hypertension: latest data and opinions","volume":"49","author":"Tsalta","year":"2008","journal-title":"Hellenic J. Cardiol."},{"issue":"9","key":"10.1016\/j.cbi.2021.109604_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.amjcard.2004.01.020","article-title":"\u03b2-blockers in hypertension: is carvedilol different","volume":"93","author":"Messerli","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cbi.2021.109604_bib13","first-page":"25","article-title":"The role of \u03b2-blockers in preventing sudden death in heart failure","volume":"6","author":"Teerlink","year":"2000","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.cbi.2021.109604_bib14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jama.287.7.883","article-title":"Beta-Blocker therapy in heart failure, Scientific review","volume":"287","author":"Foody","year":"2002","journal-title":"Jama"},{"key":"10.1016\/j.cbi.2021.109604_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bjp.0706048","article-title":"The selectivity of \u03b2\u2010adrenoceptor antagonists at the human \u03b21, \u03b22 and \u03b23 adrenoceptors","volume":"144","author":"Baker","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109604_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev.me.41.020190.001405","article-title":"Molecular mechanisms of diuretic agent","volume":"41","author":"Jacobson","year":"1990","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.cbi.2021.109604_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1258\/acb.2011.011281","article-title":"Diuretics: a review","volume":"49","author":"Wile","year":"2012","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cbi.2021.109604_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/MJT.0b013e31818d3f67","article-title":"Diuretics: an update on the pharmacology and clinical uses","volume":"16","author":"Reddy","year":"2009","journal-title":"Am. J. Therapeut."},{"key":"10.1016\/j.cbi.2021.109604_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/pgmj.2003.010843","article-title":"Use of diuretics in cardiovascular disease: (2) hypertension","volume":"80","author":"Shah","year":"2004","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.cbi.2021.109604_bib20","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1021\/bi00300a036","article-title":"Affinity chromatographic purification of angiotensin converting enzyme","volume":"23","author":"Pantoliano","year":"1984","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2021.109604_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1530\/rep.0.1220139","article-title":"Characterization of angiotensin-converting enzyme in canine testis","volume":"122","author":"Sabeur","year":"2001","journal-title":"Reproduction"},{"key":"10.1016\/j.cbi.2021.109604_bib22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0003-2697(79)90769-3","article-title":"Continuous spectrophotometric assay for angiotensin converting enzyme","volume":"95","author":"Holmquist","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cbi.2021.109604_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1570-0232(02)00663-3","article-title":"Purification of angiotensin I converting enzyme from pig lung using concanavalin-A sepharose chromatography","volume":"783","author":"Andujar-S\u00e1nchez","year":"2003","journal-title":"Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cbi.2021.109604_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cbi.2021.109604_bib25","series-title":"Principles of Biochemistry","first-page":"558","author":"Lehninger","year":"2000"},{"key":"10.1016\/j.cbi.2021.109604_bib26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2021.109604_bib27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/bj0960595","article-title":"The gel-filtration behaviour of proteins related to their molecular weights over a wide range","volume":"96","author":"Andrews","year":"1965","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2021.109604_bib28","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver","year":"1934","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.cbi.2021.109604_bib29","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/bj2920597","article-title":"Characterization of a secretase activity which releases angiotensin-converting enzyme from the membrane","volume":"292","author":"Oppong","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2021.109604_bib30","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S1357-2725(96)00086-6","article-title":"Angiotensinogen: molecular biology, biochemistry and physiology","volume":"28","author":"Morgan","year":"1996","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cbi.2021.109604_bib31","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1212\/WNL.35.8.1220","article-title":"Angiotensin converting enzyme in cerebrospinal fluid: a new assay","volume":"35","author":"Oksanen","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2021.109604_bib32","first-page":"185","article-title":"Angiotensin-converting enzyme and other peptidolytic enzymes in human semen and relations to its spermatologic parameters","volume":"2","author":"Siems","year":"1991","journal-title":"Andrologia"},{"key":"10.1016\/j.cbi.2021.109604_bib33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1357-2725(00)00072-8","article-title":"Angiotensin-converting enzymes from human urine of mild hypertensive untreated patients resemble the N-terminal fragment of human angiotensin I-converting enzyme","volume":"33","author":"Casarini","year":"2001","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cbi.2021.109604_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1590\/S0066-782X2008001500006","article-title":"Angiotensin-converting enzyme in pericardial fluid: comparative study with serum activity","volume":"91","author":"Gomes","year":"2008","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.cbi.2021.109604_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0021-9673(96)00372-X","article-title":"Purification and assay methods for angiotensin-converting enzyme","volume":"743","author":"Meng","year":"1996","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.cbi.2021.109604_bib36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0003-2697(80)90318-8","article-title":"Solubilization of pulmonary angiotensin-converting enzyme with 1-O-n-octyl-beta-D-glucopyranoside","volume":"102","author":"Lazo","year":"1980","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cbi.2021.109604_bib37","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/1523-1747.ep12510319","article-title":"Partial purification and characterization of angiotensin-converting enzyme in mouse and human skin","volume":"78","author":"Hara","year":"1982","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cbi.2021.109604_bib38","article-title":"Investigation of inhibition effect of butanol and water extracts of Matricaria chamomilla L. on Angiotensin-Converting Enzyme purified from human plasma","author":"Bas","year":"2021","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.cbi.2021.109604_bib39","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1080\/10826079608014029","article-title":"Preparative isolation of a soluble form of bovine lung angiotensin converting enzyme by affinity and size exclusion chromatography","volume":"19","author":"Fuentes","year":"1996","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.cbi.2021.109604_bib40","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1021\/bi00766a011","article-title":"Angiotensin I converting enzyme of calf lung. Method of assay and partial purification","volume":"11","author":"Stevens","year":"1972","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2021.109604_bib41","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.1016\/S0021-9258(19)40997-6","article-title":"Pulmonary angiotensin-converting enzyme. Structural and catalytic properties","volume":"250","author":"Das","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2021.109604_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4175","article-title":"Purification of angiotensin\u2013converting enzyme from human plasma and investigation of the effect of some active ingredients isolated from Nigella sativa L. extract on the enzyme activity","volume":"32","author":"Basi","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.cbi.2021.109604_bib43","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","article-title":"Angiotensin-converting enzyme inhibitors","volume":"97","author":"Brown","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2021.109604_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-510X(02)00281-2","article-title":"Protective effect of antihypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data","volume":"203\u2013204","author":"Amenta","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cbi.2021.109604_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/hr.2009.184","article-title":"Reinventing the ACE inhibitors: some old and new implications of ACE inhibition","volume":"33","author":"Hanif","year":"2010","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.cbi.2021.109604_bib46","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3109\/00365518009095586","article-title":"Purification of human lung angiotensin-converting enzyme","volume":"40","author":"Gr\u00f6nhagen-Riska","year":"1980","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"10.1016\/j.cbi.2021.109604_bib47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jchromb.2018.11.023","article-title":"In vitro effect of oxidized and reduced glutathione peptides on angiotensin converting enzyme purified from human plasma","volume":"1104","author":"Basi","year":"2019","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cbi.2021.109604_bib48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0002-9343(88)90349-X","article-title":"Antihypertensive and renal effects of lisinopril in older patients with hypertension","volume":"85","author":"Laher","year":"1988","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cbi.2021.109604_bib49","first-page":"834","article-title":"Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity","volume":"47","author":"Rosolova","year":"2001","journal-title":"Vnitr. Lek."},{"key":"10.1016\/j.cbi.2021.109604_bib50","first-page":"1095","article-title":"Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney","volume":"84","author":"Bern\u00e1tov\u00e1","year":"1999","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.cbi.2021.109604_bib51","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.0954-6820.1981.tb02628.x","article-title":"Captopril in primary hypertension: effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems","volume":"209","author":"\u00d6hman","year":"1981","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.cbi.2021.109604_bib52","first-page":"7","article-title":"Beta-blockers in cardiovascular medicine","volume":"57","author":"Mansoor","year":"2009","journal-title":"J. Assoc. Phys. India"},{"key":"10.1016\/j.cbi.2021.109604_bib53","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/01.CIR.0000065187.80707.18","article-title":"\u03b2-blockers in chronic heart failure","volume":"107","author":"Gheorghiade","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2021.109604_bib54","first-page":"13","article-title":"Atenolol drug profile","volume":"57","author":"Wander","year":"2009","journal-title":"Suppl. Japi"},{"key":"10.1016\/j.cbi.2021.109604_bib55","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/01.CIR.64.2.368","article-title":"Clinical evaluation of atenolol in hypertensive patients","volume":"64","author":"Ibrahim","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2021.109604_bib56","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2125.2010.03742.x","article-title":"Atenolol blunts blood pressure increase during dynamic resistance exercise in hypertensives","volume":"70","author":"Gomides","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109604_bib57","series-title":"Clinical Management of Poisoning and Drug Overdose","first-page":"1315","author":"Haddad","year":"1990"},{"key":"10.1016\/j.cbi.2021.109604_bib58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00432296","article-title":"Effects of atenolol and propranolol on human performance and subjective feelings","volume":"60","author":"Landauer","year":"1979","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.cbi.2021.109604_bib59","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11606-015-3469-1","article-title":"Triamterene enhances the blood pressure lowering effect of hydrochlorothiazide in patients with hypertension","volume":"31","author":"Tu","year":"2016","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.cbi.2021.109604_bib60","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/B978-012635690-8\/50016-5","article-title":"Chapter IVC3 - interactions between ace inhibitors and diuretics","author":"Cleland","year":"1997","journal-title":"Diuretic Agents Clin. Physiol. Pharmacol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279721002428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279721002428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:04:21Z","timestamp":1757858661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279721002428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":60,"alternative-id":["S0009279721002428"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109604","relation":{},"ISSN":["0009-2797"],"issn-type":[{"type":"print","value":"0009-2797"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced purification protocol for the angiotensin-converting enzyme from bovine systems and investigation of the in vitro effect of some active substances","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109604"}}